Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives

Wiener klinische Wochenschrift
Peter ValentChristoph Zielinski

Abstract

In 2008 the Ludwig Boltzmann Cluster Oncology (LBC ONC) was established on the basis of two previous Ludwig Boltzmann Institutes working in the field of hematology and cancer research. The general aim of the LBC ONC is to improve treatment of hematopoietic neoplasms by eradicating cancer-initiating and disease-propagating cells, also known as leukemic stem cells (LSC) in the context of leukemia. In a first phase, the LBC ONC characterized the phenotype and molecular aberration profiles of LSC in various malignancies. The LSC phenotypes were established in acute and chronic myeloid leukemia, in acute lymphoblastic leukemia and in chronic lymphocytic leukemia. In addition, the concept of preleukemic (premalignant) neoplastic stem cells (pre-L-NSC) was coined by the LBC ONC and was tested in myelodysplastic syndromes and myeloproliferative neoplasms. Phenotypic characterization of LSC provided a solid basis for their purification and for the characterization of specific target expression profiles. In a second phase, molecular markers and targets were validated. This second phase is ongoing and should result in the development of new diagnostics parameters and novel, more effective, LSC-eradicating, treatment strategies; however, m...Continue Reading

References

Nov 2, 2001·Nature·T ReyaI L Weissman
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Jan 23, 2004·Nature Reviews. Cancer·Ricardo PardalSean J Morrison
Mar 17, 2004·Cancer Control : Journal of the Moffitt Cancer Center·Monica L Guzman, Craig T Jordan
Apr 28, 2004·Current Opinion in Genetics & Development·Muhammad Al-HajjMichael F Clarke
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wolfgang R SperrPeter Valent
Aug 5, 2004·European Journal of Clinical Investigation·W R SperrP Valent
Aug 13, 2004·The New England Journal of Medicine·Catriona H M JamiesonIrving L Weissman
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria-T KrauthPeter Valent
Mar 8, 2006·Nature Medicine·Kornelia Polyak, William C Hahn
Oct 14, 2006·Cancer·Axel SchulenburgPeter Valent
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Dec 22, 2006·European Journal of Clinical Investigation·A W HauswirthP Valent
Jan 4, 2007·Nature Genetics·Martin WidschwendterPeter W Laird
Jan 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·M E PrinceL E Ailles
Jan 19, 2008·Nature·Tobias SchattonMarkus H Frank
Apr 24, 2008·Nature Clinical Practice. Oncology·Andreas Trumpp, Otmar D Wiestler
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan E Zabierowski, Meenhard Herlyn
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carol Ann Huff, William Matsui
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward KavalerchikCatriona H M Jamieson
Dec 5, 2008·Nature·Connie J Eaves
Dec 5, 2008·Nature·Elsa QuintanaSean J Morrison
Oct 29, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M-T KrauthP Valent
Feb 27, 2010·Critical Reviews in Oncology/hematology·Axel SchulenburgPeter Valent
Apr 3, 2010·Seminars in Cancer Biology·Mel Greaves
Apr 29, 2010·Current Hematologic Malignancy Reports·G Vignir HelgasonTessa L Holyoake
Apr 29, 2010·Current Hematologic Malignancy Reports·Mhairi Copland
Jun 29, 2010·Critical Reviews in Oncology/hematology·J Loeffler-RaggR Stauder
Jul 21, 2010·Wiener klinische Wochenschrift·Heidrun KarlicPeter Valent
Sep 24, 2010·Leukemia·I SlomaC J Eaves
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marina Y Konopleva, Craig T Jordan
Apr 6, 2011·The Journal of Experimental Medicine·Emmanuelle ClappierJean Soulier

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
flow cytometry
MDS

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

[Rinshō ketsueki] The Japanese journal of clinical hematology
Noriyasu FukushimaShinya Kimura
[Rinshō ketsueki] The Japanese journal of clinical hematology
Tomoya MutoAtsushi Iwama
© 2022 Meta ULC. All rights reserved